Close

Stay informed

Drop us your email and we’ll keep you up-to-date on Medicaid issues.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Letter ·

NAMD Provides Thoughts on High-Cost Drugs to Senate Finance

In March 2016, NAMD responded to a Senate Finance Committee Request for Information on prescription drug costs and coverage.

Author
Focus Areas
Program Stream

In March 2016, NAMD responded to a series of questions from the Senate Finance Committee on how to account for value in the pricing and coverage of breakthrough prescription drug therapies. The letter outlines potential policy options for improving the Medicaid Drug Rebate Program and other options to grant states additional tools for managing the impact of these drugs on the Medicaid program.

Related resources

Stay Informed

Drop us your email and we’ll keep you up-to-date on Medicaid issues.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.